ArticleCase reports in obstetrics and gynecology2026
Pyoderma Gangrenosum Following Cesarean Section: A Case Report With Individualized Management.
Article in Case reports in obstetrics and gynecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pyoderma Gangrenosum Following Cesarean Section: A Case Report With Individualized Management.Case reports in obstetrics and gynecology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis characterized by rapidly progressive necrotizing skin ulcers. PG following cesarean section (CS) is extremely rare and frequently misdiagnosed as surgical site infection, leading to inappropriate debridement and disease exacerbation. We report a case of severe postcesarean PG successfully managed with early immunosuppressive therapy. Case Presentation: A 24-year-old primiparous woman at 29 + 4 weeks gestation underwent emergency CS due to umbilical cord prolapse. On postoperative day (POD) 7, she developed painful ulcers with undermined violaceous borders around the incision. Despite broad-spectrum antibiotics, lesions progressed rapidly. Pathergy occurred following surgical debridement on POD 9 (wound enlarged to 21.5 × 11.0 cm). PG was diagnosed on POD 11 based on clinical features, sterile cultures, and neutrophilic infiltrate on histopathology. Treatment included methylprednisolone pulse therapy (500 mg intravenously daily for 3 days), followed by tapering to 60 mg/day with concurrent initiation of cyclosporine (75 mg oral twice daily) and etanercept (25 mg subcutaneously twice weekly). The patient was discharged on POD 30. Complete epithelialization was achieved by the 4th postoperative month without recurrence or adverse drug reactions. Discussion: This case highlights the diagnostic challenges of postcesarean PG, which requires high clinical suspicion to distinguish from infectious complications. Triple immunosuppressive therapy (high-dose corticosteroids, calcineurin inhibitor, and TNF-
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.